GEM 5000 CAP 6 Month Cal/Ver, Linearity, AMR, and Reference Range Verification
20 followers
0 Likes
I am working on the CAP 6 month Cal/Ver, AMR, Reference Range and Linearity study on my GEM 5000’s. We usually use PVP to complete this in addition to patient samples to correlate to the lab. I have 3 devices in use where two are in OR and one in the Cath Lab. One of the Gem 5000’s in the OR is measuring lower than the TAE from the mean on tHb for PVP 1. When the last 6-month study was completed the instrument was in range of the tHb TAE. I have used 3 cartridge lots and run two different lots of PVP 1 (total of19 samples) and it will not pass TAE tHb on the low PVP 1.
CAP has made the TAE much narrower as well. It fails both the 7% and the new TAE of 4% on the low end. The other devices are fine. The field technician has changed the tension on the tubing and run diagnostic tests in house and he has taken it out for further extensive testing. He states is passes all diagnostic tests. It has failed PVP all along. Currently the instrument is out of service because of this. Werfen states it is ok to use based on their TAE listed in the GEM 5000 manual of +/- 0.7 for tHb < 18 g/dL. This is not compatible with CAP. Werfen has stated that no further service is needed. I am wondering if anyone has encountered any issues with your GEM similar to this situation.
Thank you!
5 Replies
Reply
Subgroup Membership is required to post Replies
Join POCT Listserv now
Suggested Posts
| Topic | Replies | Likes | Views | Participants | Last Reply |
|---|---|---|---|---|---|
| POC ammonia test | 0 | 0 | 166 | ||
| Glucose Meter Strip Validations | 4 | 0 | 322 | ||
| FOB - moving away from POC | 10 | 0 | 491 |
In CAP POC and All Common Checklists I could not find requirement to use CLIA’s proficiency standards for AMR studies, Linearity, or LQC acceptability requirements. I did find the requirements to follow Manufacturer process and when the manufacturer does not define a process to follow the Laboratory Medical Directors acceptability requirements.
I look forward to seeing other folks thoughts on this question.
I believe that this issue for the lab is going to become more prevalent as more facilities run into this. I've already come across this with Nova and had a discussion about it with Werfen as well. Both Nova and Werfen take similar positions.
Issue:
The Platforms (Gem, Prime+, Radiometer) were approved by the FDA with the system defined TAE. These manufacturers are NOT going to change the TAE now: it was approved.
CLIA / CAP now says they need to be more accurate... lower TAE.... This issue doesn't become immediately apparent until:
Example:
I've been having our acceptable QC ranges tightened beyond the manufacturer's defined AMR to address this.
We are being caught between regulatory agencies and the manufacturers. I understand the desire to tighten the ranges; I also understand the manufacturers position as well.